NCT03755232View on ClinicalTrials.gov

Acute Glycemic and Insulinemic Response of FOSSENCE™

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 6, 2018

Primary Completion Date

February 27, 2019

Study Completion Date

September 9, 2019

Conditions
Dietary ModificationHealthy
Interventions
DIETARY_SUPPLEMENT

scFOS

Fossence™ (short chain Fructo-oligosaccharides (scFOS)

OTHER

Control

water or dextrose or white bread

Trial Locations (1)

M5C 2N8

INQUIS Clinical Research (formerly GI Labs), Toronto

Sponsors
All Listed Sponsors
collaborator

Glycemic Index Laboratories, Inc

INDUSTRY

lead

TATA CHEMICALS LTD

INDUSTRY

NCT03755232 - Acute Glycemic and Insulinemic Response of FOSSENCE™ | Biotech Hunter | Biotech Hunter